Monitoring Individuals with T1D Islet Autoantibodies: Consensus Guidance

Expert consensus on monitoring individuals with T1D islet autoantibodies: detection, monitoring frequency, and psychosocial support for managing autoimmune T1D.

Learning Objectives

Understand the process for confirming islet autoantibody status in adults and children
Learn the recommended monitoring frequencies for T1D
Explore the importance of psychosocial support for individuals with IAb+

Summary

This infographic outlines the key steps for confirming single and multiple IAb+ status in adults and children at risk for type 1 diabetes (T1D). Tailored recommendations for monitoring frequencies are provided based on individual risk factors, such as genetic predisposition and glycemic control.

This infographic also underscores the essential role of psychosocial support, emphasizing the need to address emotional and behavioral health alongside physical monitoring. This expert guidance may support healthcare providers to effectively manage and support individuals with positive T1D-islet autoantibodies.

Download

Screening Stages of T1D

MAT-GLB-2404919-1.0 – 09/2024

Type 1 Diabetes: Mechanism of Beta Cell Loss Caused by Autoimmune T Cells

This animated video provides an overview of the key immunological processes that underlie the development of autoimmunity in T1D. Autoreactive T cells drive pancreatic beta-cell destruction, resulting in insulin deficiency and, ultimately, hyperglycemia and symptoms of T1D.

Discover more

Disease Burden
Video

Exploring the Impact of Diagnosis

The burden associated with a diagnosis of autoimmune T1D can be wide-ranging. This video describes the impact of diagnosis on an individual and their family.